Skip to main content
. 2017 Jul 28;96(30):e7606. doi: 10.1097/MD.0000000000007606

Figure 1.

Figure 1

Effect of SLE treatment on viability of LNCaP cells. Cells were treated with SLE for 24 h. The cell viability was measured using the MTT assay. Values are mean ± S.E.M of 3 independent experiments. P < .05, significantly different from untreated cells. LNCaP = lymph node carcinoma of the prostate, MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.